The Gastrointestinal Products Market is being driven by Rising prevalence of gastrointestinal disorders
The Gastrointestinal Products Market is expected to grow at a CAGR of 6.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 5376.8 million. In the realm of gastrointestinal (GI) diagnostics, the integration of artificial intelligence (AI) into endoscopic devices is revolutionizing the industry. At the Genius Summit 2024 on April 10, 2024, Medtronic plc showcased its latest advancements in AI-driven endoscopic care. The company introduced ColonPRO, an advanced software for the GI Genius intelligent endoscopy system. This next-generation software, which boasts an expanded dataset, enhances polyp detection accuracy by reducing false positives by 9%. Furthermore, ColonPRO offers new procedural highlights that streamline workflows and lessen administrative burdens, thereby increasing the efficiency of endoscopic procedures for healthcare providers. This technological innovation significantly contributes to better patient outcomes by improving real-time image analysis, lesion detection, and polyp classification.
Get more information on Gastrointestinal Products Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
215 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.5% |
|
Market growth 2025-2029 |
USD 5376.8 million |
|
Market structure |
market_structure.ucfirst |
|
YoY growth 2024-2025(%) |
5.9 |
|
Key countries |
US, Germany, China, Japan, UK, France, Canada, Italy, South Korea, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Gastrointestinal Products Market encompasses a range of offerings aimed at promoting health and managing various conditions, including inflammatory bowel disease (IBD), Crohn's disease, and other digestive disorders. Over-the-counter medications and rectal medications offer relief from pain and discomfort, while therapies like endoscopy and surgery provide more intensive treatment. Specialist care and patient education are crucial for effective disease management. Prevention through nutritional supplements, prebiotics, probiotics, and functional foods targets chronic diseases and gut health. Biomarkers, immune system support, and genetic testing contribute to disease burden reduction and healthcare cost savings. Inflammation, motility, and gut microbiome are key areas of focus for disease prevention and healthspan enhancement. Cancer prevention and intestinal health are significant aspects of this market.
The gastrointestinal products market encompasses the revenue generated from the sales of antidiarrheal medications, OTC drugs, and prescription therapies such as biological medications and anti-inflammatory drugs. This market size is calculated by Technavio, taking into account the combined revenue of manufacturers and providers in the healthcare sector, including those specializing in equipment, supplies, pharmaceuticals, biotechnology, healthcare technology, and life sciences tools and services. Factors driving market growth include the need to reduce healthcare costs, regulatory approvals for innovative treatments like upadacitinib for gastrointestinal conditions such as gastroenteritis and asthma, and the integration of technology in healthcare delivery.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
